Help your patients finally sleep better again!
App on prescription for treating sleep disorders
GOP: 01471 (64 points)
GOP for pain therapists: 30780 (64 points)
Indication: F51.0, G47.0
Clinical efficacy of somnio
The clinical efficacy of somnio was proven in an RCT study conducted by the University of Zurich. The results demonstrated a positive healthcare effect:
- On average, insomnia symptoms of somnio users were reduced by 50%.
- The time they spent awake at night was reduced by an average of 31 minutes.
- With somnio, users were able to fall asleep 18 minutes faster on average.
- Even 12 months later, the treatment effects remained stable.
Find out more about the clinical efficacy and the positive healthcare effect of somnio.
Wie funktioniert somnio?
Erhalten Sie mithilfe unseres Produktvideos schnell und einfach einen Einblick in die Funktionsweise von somnio.
Advantages for HCP
Around 35% of the adult population in Germany occasionally have sleep problems, while between 7 and 10% of the adult population from clinically relevant insomnia.
The S3 guideline recommends cognitive behavioral therapy for insomnia (CBT-I) as the treatment method of first choice for non-organic insomnia in adults. In reality, however, only very few people get access to this highly effective treatment.
Six advantages of using somnio
(PZN: 16898724)
by treating insomnia with digital CBT-I
Information material
Was möchten Sie nachbestellen?
CME-certified training courses
Earn CME credits and learn more about digital health applications (DiGA) in practice and discover new ways to treat insomnia.
somnio live and on site
Unsere On-demand Webinare
Wie wird eine DiGA zur DiGA?
Komorbide Insomnie und Schlafapnoe - COMISA
Kognitive Verhaltenstherapie bei Insomnie - KVT-I
Komorbide Insomnie bei psychiatrischen Erkrankungen
somnio - Evidenz
This is what physicians say about somnio
Interviewing sleep physicians
Data privacy & security
As a DiGA, somnio fully complies with the requirements for data protection and information security as required by the General Data Protection Regulation and the Digital Health Applications Ordinance (DiGAV). mementor has been certified according to ISO/IEC 27001, providing objective and reliable evidence of the effectiveness of our Information Security Management System (ISMS).
Any questions about somnio?
You can reach us by phone (Mon. - Fri. from 8 a.m. - 5 p.m.), e-mail and contact form. We respond within 24 hours:
FAQ
somnio is the first digital health application (DiGA) in the field of sleep medicine that has received a permanent approval by the Federal Institute for Drugs and Medical Devices (BfArM). It can therefore be prescribed by all physicians and psychotherapists in Germany.
somnio is suitable for patients with non-organic insomnia (F51.0) or problems falling and staying asleep (G47.0). Patients with this diagnosis suffer from difficulty falling asleep and staying asleep several times a week over a longer period of time, and feel that their daytime well-being is impaired due to these sleep problems.
The use of somnio is not suitable for people who are currently in an acute crisis, especially in the presence of suicidal ideation and/or intentions.
Just like other digital health applications (DiGA), somnio can be prescribed as an app on prescription in Germany. Just write the PZN 16898724 and the app's name somnio on the pink prescription form (template 16). The diagnosis and the prescription period do not have to appear on the prescription. Alternatively, the prescription is also possible using a proof of diagnosis. You can download a template for statutory health insurances / for private health insurances here.
somnio can be prescribed by physicians and psychotherapists of all specialties.
The "Evaluation and follow-up in connection with the somnio application" can be billed with GOP 01471 (64 points) and with the newly created GOP 30780 (for pain therapists, 64 points). The follow-up can be done either verbally only or with the help of a printed program report from the patient or with the help of the monitor (app.somn.io/doc). Payment for this service is extrabudgetary.
GOP 30780 can only be billed by panel doctors who have an authorization from the responsible Association of Statutory Health Insurance Physicians (KV) in accordance with the Quality Assurance Agreement for the Pain Therapy of Patients with Chronic Pain (Qualitätssicherungsvereinbarung Schmerztherapie) in accordance with Section 135 (2) SGB V.
DiGA apps are billed on an extrabudgetary basis and do not burden your drug or remedy budget.
In order to analyze the patient's progress data, you can use the printed patient report or access the patient's data via the online medical report (see below). Alternatively, you can also conduct the discussion verbally. In all cases, GOP 01471 (64 points) or the newly created GOP 30780 (for pain therapists, 64 points) can be used for billing.
The medical report can be used during consultation hours. It works as follows:
1. Access code from patient/link to query
Ask your patient to generate the 8-digit access code and give it to you. They can do so by clicking on “Medical Report” in the app menu.
Optionally, you can ask your patient to send you a link granting you access to their medical report. The link can be found in the menu under “Medical report” and is valid for one month. It will give you direct insight into the report.
2. Start medical report and request access
Open the medical report under app.somn.io/doc and enter your name and access code (by entering your name the patient can verify your identity).
3. Wait for confirmation
As soon as the patient has confirmed your access request in the app, you can view the evaluation.
The usage of the medical report is voluntary.
Yes, it is possible to have psychological psychotherapy accompanied by a treatment with somnio.
This is no problem, of course. Patients can also contact their health insurance company themselves and request an additional license code, as they already have an indication. Patients can subsequently enter the new license code in their profile settings to have the license extended. By doing so, their previous progress will be maintained.
In the course of the RCT study conducted by the University of Zurich, patients diagnosed with insomnia were assigned randomly to an intervention group (using somnio) or a waitlist control group. Patients in the intervention group experienced a 50% reduction in their insomnia symptoms over the treatment period, whereas patients in the control group reported no significant change. In addition, the intervention group's patients were able to reduce significantly the time it took them to fall asleep and the time they spent awake in bed at night. The treatment effect was still measurable 12 months after the trial ended (follow-up). After using somnio, 56% of participants in the treatment group achieved remission, compared to only 11% in the control group (remission criterion = ISI score < 8), which corresponds to an NNT of 2.23. The study can be found here.
Data storage of digital health applications (DiGA) is subject to strict requirements, which is why for somnio, we completely refrain from using US American cloud providers (such as GCP, AWS) and have the data processed in Germany exclusively. Patient data will not be passed on to third parties, nor will health insurance companies receive it. The users maintain data sovereignty at all times and can have their data deleted on their own request.
All relevant information can be found in the BfArM DiGA directory : diga.bfarm.de
No problem. As a psychotherapist (PP and KJP), you can just enter the following fictitious physician number 999999999 (9×9). You can order the prescription sheet 16 in larger quantities from printing companies or directly from us in smaller quantities.
